FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:290-292 July 27, 2000 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pieterman, R. M. PubMed Citation

Carcinoma of the lung is the leading cause of death from cancer in Western countries. Surgery is the treatment most likely to result in the cure of early non–small-cell lung carcinoma, which includes squamous-cell carcinoma, adenocarcinoma, and large-cell carcinoma. In contrast, at presentation small-cell lung cancer (oat-cell carcinoma) has almost always spread, and patients with this form of lung cancer are not candidates for resection. Since tumor involvement of mediastinal lymph nodes limits the chance of a surgical cure of non–small-cell lung cancer, accurate staging of disease in the mediastinum is essential. For patients with disease classified as stage I . . . [Full Text of this Article]

References

Related Letters:

Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
Miller Y. E., Rosell R., Donckier J. E., Roelants V., Pochet J.-M., Groen H. J.M.
Extract | Full Text  
N Engl J Med 2000; 343:1571-1573, Nov 23, 2000. Correspondence

This article has been cited by other articles:

• Yasufuku, K., Nakajima, T., Motoori, K., Sekine, Y., Shibuya, K., Hiroshima, K., Fujisawa, T. (2006). Comparison of Endobronchial Ultrasound, Positron Emission Tomography, and CT for Lymph Node Staging of Lung Cancer.. Chest 130: 710-718 [Abstract] [Full Text]  
• Lardinois, D., Weder, W., Roudas, M., von Schulthess, G. K., Tutic, M., Moch, H., Stahel, R. A., Steinert, H. C. (2005). Etiology of Solitary Extrapulmonary Positron Emission Tomography and Computed Tomography Findings in Patients With Lung Cancer. JCO 23: 6846-6853 [Abstract] [Full Text]  
• Viney, R. C., Boyer, M. J., King, M. T., Kenny, P. M., Pollicino, C. A., McLean, J. M., McCaughan, B. C., Fulham, M. J. (2004). Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer. JCO 22: 2357-2362 [Abstract] [Full Text]  
• Schwartzenberg-Bar-Yoseph, F., Armoni, M., Karnieli, E. (2004). The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression. Cancer Res. 64: 2627-2633 [Abstract] [Full Text]  
• Fritscher-Ravens, A., Davidson, B. L., Hauber, H.-P., Bohuslavizki, K. H., Bobrowski, C., Lund, C., Knofel, W. T., Soehendra, N., Brandt, L., Pepe, M. S., Pforte, A. (2003). Endoscopic Ultrasound, Positron Emission Tomography, and Computerized Tomography for Lung Cancer. Am. J. Respir. Crit. Care Med. 168: 1293-1297 [Abstract] [Full Text]  
• Leschber, G., Holinka, G., Linder, A. (2003). Video-assisted mediastinoscopic lymphadenectomy (VAMLA) - a method for systematic mediastinal lymphnode dissection. Eur. J. Cardiothorac. Surg. 24: 192-195 [Abstract] [Full Text]  
• Israel, O., Mor, M., Gaitini, D., Keidar, Z., Guralnik, L., Engel, A., Frenkel, A., Bar-Shalom, R., Kuten, A. (2002). Combined Functional and Structural Evaluation of Cancer Patients with a Hybrid Camera-Based PET/CT System Using 18F-FDG. JNM 43: 1129-1136 [Abstract] [Full Text]  
• Salminen, E., Mac Manus, M. (2002). FDG-PET imaging in the management of non-small-cell lung cancer. Ann Oncol 13: 357-360 [Abstract] [Full Text]  
• Miller, Y. E., Rosell, R., Donckier, J. E., Roelants, V., Pochet, J.-M., Groen, H. J.M. (2000). Staging of Non-Small-Cell Lung Cancer with Positron-Emission Tomography. NEJM 343: 1571-1573 [Full Text]